Literature DB >> 2565322

Short-term somatostatin infusion affects T lymphocyte responsiveness in humans.

P Malec1, K Zeman, K Markiewicz, H Tchórzewski, Z Nowak, Z Baj.   

Abstract

Peripheral blood lymphocytes (PBL) function was analysed in 16 young men with duodenal ulcers after one-hour intravenous infusion of somatostatin (SMS) at a dose of 250 micrograms/h. Proliferative responses of PBL from SMS-treated patients were significantly diminished compared with pre-treatment values, after stimulation with PHA, PWM or Con A. Spontaneous IL-2R expression was moderately increased after SMS infusion but PHA-induced IL-2R expression was not affected by this drug. Alloantigen and autoantigen stimulation of PBL showed no significant changes in the proliferative response after SMS infusion. NK cell activity was similarly unaffected. These observations establish a link between SMS exposure and possible development of immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565322     DOI: 10.1016/0162-3109(89)90007-6

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  7 in total

1.  Octreotide and urinary glycosaminoglycan in Graves' disease.

Authors:  T C Chang; W C Yao; C C Chang
Journal:  BMJ       Date:  1992-05-30

Review 2.  The neuroendocrine-immune axis.

Authors:  F Homo-Delarche; M Dardenne
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Expression of the somatostatin gene in human astrocytoma cell lines.

Authors:  L Mercure; G S Tannenbaum; H M Schipper; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

4.  Somatostatin analogue scintigraphy in granulomatous diseases.

Authors:  P M Vanhagen; E P Krenning; J C Reubi; D J Kwekkeboom; W H Bakker; A H Mulder; I Laissue; H C Hoogstede; S W Lamberts
Journal:  Eur J Nucl Med       Date:  1994-06

Review 5.  Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy.

Authors:  G E Krassas
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 6.  Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

Authors:  Magdy El-Salhy; Tefera Solomon; Trygve Hausken; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

7.  Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.

Authors:  K J O'Byrne; J T Ennis; P J Freyne; L J Clancy; J S Prichard; D N Carney
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.